Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer.
Cunningham, David; Humblet, Yves; Siena, Salvatore; Khayat, David; Bleiberg, Harry; Santoro, Armando; Bets, Danny; Mueser, Matthias; Harstrick, Andreas; Verslype, Chris; Chau, Ian; Van Cutsem, Eric; New England Journal of Medicine, 2004, vol. 351, issue 4, p 337, ISSN 00284793. ISBN 00284793.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef